I
n a victory for the pharmaceutical industry, the U.S. Supreme Court limited the right for people from anywhere in the country to file product-liability lawsuits against drug makers in California and several other states where courts are seen as more hospitable to consumers.
The ruling came in response to a debate over jurisdiction, which can be used to determine where a lawsuit may be filed. Last year, the California Supreme Court clarified the extent to which Bristol-Myers Squibb needed to have a presence in California in order to be sued by hundreds of people from Texas, Ohio, and 33 other states, who claim they were harmed by its Plavix blood thinner.
This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.
About the Author
